142 related articles for article (PubMed ID: 8094983)
21. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
[TBL] [Abstract][Full Text] [Related]
22. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
23. Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.
Zhang C; Xu JM; Kong DR; Min XK; Chen R
J Clin Pharm Ther; 2013 Jun; 38(3):206-11. PubMed ID: 23437909
[TBL] [Abstract][Full Text] [Related]
24. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease.
Matrella E; Valatas V; Notas G; Roumpaki H; Xidakis C; Hadzidakis A; Mouzas I; Kouroumalis E
Aliment Pharmacol Ther; 2001 Jun; 15(6):857-64. PubMed ID: 11380324
[TBL] [Abstract][Full Text] [Related]
25. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
[TBL] [Abstract][Full Text] [Related]
27. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis.
Ota K; Shijo H; Kokawa H; Kubara K; Kim T; Akiyoshi N; Yokoyama M; Okumura M
J Gastroenterol Hepatol; 1995; 10(2):198-204. PubMed ID: 7787167
[TBL] [Abstract][Full Text] [Related]
28. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis.
Eriksson LS; Brundin T; Söderlund C; Wahren J
Scand J Gastroenterol; 1987 Oct; 22(8):919-25. PubMed ID: 2891184
[TBL] [Abstract][Full Text] [Related]
29. [Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension].
Huang Z; Guo B; Liang K
Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):15-8. PubMed ID: 9275639
[TBL] [Abstract][Full Text] [Related]
30. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis.
Chiang HT; Cheng JS; Lin M; Tseng WS; Chang JM; Lai KH
J Gastroenterol Hepatol; 1995; 10(3):256-60. PubMed ID: 7548800
[TBL] [Abstract][Full Text] [Related]
32. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
33. Effect of vasopressin and somatostatin on hemodynamics and blood gases in patients with liver cirrhosis.
Naeije R; Hallemans R; Mols P; Mélot C; Reding P
Crit Care Med; 1982 Sep; 10(9):578-82. PubMed ID: 6125342
[TBL] [Abstract][Full Text] [Related]
34. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Baxter JN; Corbett WA; Shields R
Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
[TBL] [Abstract][Full Text] [Related]
35. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis.
Pringle SD; McKee RF; Garden OJ; Lorimer AR; Carter DC
Aliment Pharmacol Ther; 1988 Oct; 2(5):451-9. PubMed ID: 2979267
[TBL] [Abstract][Full Text] [Related]
36. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
Cerini R; Lee SS; Hadengue A; Koshy A; Girod C; Lebrec D
Gastroenterology; 1988 Mar; 94(3):703-8. PubMed ID: 2892752
[TBL] [Abstract][Full Text] [Related]
37. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
Willems B; Villeneuve JP; Huet PM
Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
Jenkins SA; Nott DM; Baxter JN
HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
[TBL] [Abstract][Full Text] [Related]
39. Effect and mechanism of action of isosorbide-5-mononitrate.
Hayes PC; Westaby D; Williams R
Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
[TBL] [Abstract][Full Text] [Related]
40. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
Herz R; Rössle M; Bonzel T; Keller E; Gerok W
Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
